Table 3.

Odds ratios and confidence intervals describing the associations between putative markers of previous ZCL and the immune status at baseline for individuals of the study.

1st test	Cut-off 1st test	2nd test	Cut-off 2nd Test	N	Odds ratio	Confidence intervals	p-value
LST	5	Grz B	2000	453	4.6*	3.3–6.4	<0.001
Scar	–	Grz B	2000	453	2.6*	2.03–3.3	<0.001
Scar	–	LST	5	453	2.7*	2.18–3.34	<0.001

LST, Leishmanin skin test; Cic, Presence/ansence of ZCL scar; Grz B, levels of granzyme measured within supernatant of PBMCs stimulated with L.major promastigotes; N, number of subject included in the study;

^*Statistically significant (p < 0.05).